STAT3 and cancer: We observed that blockade of endothelial cell-derived IL-6 inhibited STAT3 phosphorylation in cancer cells [26] and expression of CXCL8 (IL-8), a potent pro-angiogenic factor that is strongly correlated with tumor microvessel density [46].